CD274 and neoplasm: Additional strategies include microRNA (miRNA) and small interfering RNA (siRNA) to suppress PD-L1 transcription/translation and nanoparticle-based delivery to remodel the tumor microenvironment (TME) and enhance therapeutic efficacy [75,76].